Results 161 to 170 of about 31,267 (233)

Efficacy and safety of Doxycycline versus Macrolides for <i>Mycoplasma pneumoniae</i> INfectiOn in Children (DOMINO): a protocol for a multicentre, randomised, open-label, superiority trial. [PDF]

BMJ Open
Choi YY, Kang C, Choe YJ, Yoo Y, Shin A, Kim DR, Ahn B, Eun BW, Kim G, Kang HM, Kim YJ, Cho YK, Lee H, Kim YK, Choi JH, Yun KW, Jo KJ, Kim KR, Lee TJ, Choi UY, Yoon YS, Kim J, Kang MS, Park SK, Yang WM, Lee S.   +25 more
europepmc   +1 more source

Clinical characteristics and risk factors of necrotizing pneumonia secondary to severe pneumonia in children. [PDF]

Front Pediatr
Che L, Zhou W, Chen Q, Cheng F, Tian J.
europepmc   +1 more source

Mycoplasma pneumoniae Pneumonia: Current Perspectives [PDF]

Clinical Infectious Diseases, 1999
openaire   +2 more sources

Nonlinear age-season dynamics and macrolide resistance of Mycoplasma pneumoniae: a large pediatric cohort study during the post-pandemic resurgence. [PDF]

BMC Infect Dis
Chen H, Fan Y, Zhang X, Huang Y.
europepmc   +1 more source

Targeted next-generation sequencing reveals pathogen spectrum, drug resistance characteristics, and clinical determinants in children with community-acquired pneumonia. [PDF]

Transl Pediatr
Cai PP, Shen D, Yan RH, Wen JT, Zhang CS, Chen B.   +5 more
europepmc   +1 more source

Corticosteroids for <i>Mycoplasma pneumoniae</i> community-acquired pneumonia: promising evidence from a randomised controlled trial. [PDF]

Lancet Reg Health Eur
Teja B, Marshall JC.
europepmc   +1 more source

CRP and D-dimer for risk stratification of cerebral infarction in children with <i>Mycoplasma pneumoniae</i> pneumonia: a retrospective study. [PDF]

Front Neurol
Deng H, Lv T, Liu F, Zhao D, Huang X, Qiu D.   +5 more
europepmc   +1 more source

Impact of Allergic Diseases or Obstructive Sleep Apnea Risk on Severe <i>Mycoplasma pneumoniae</i> Pneumonia in Children: A Clinical Study and Nomogram Construction. [PDF]

J Clin Med
Yu Z, Song J, Fu Y, Li R, Ma R, Feng T, Zhang M, Jin S, Zhang X.   +8 more
europepmc   +1 more source

Analysis of risk factors for the development of bronchiolitis obliterans in children with severe <i>Mycoplasma pneumoniae</i> pneumonia. [PDF]

Front Med (Lausanne)
Hou J, Sun R, Ding Z, Jia W, Li P, Fu S, Song C.   +6 more
europepmc   +1 more source

Machine learning-based prediction of severe <i>Mycoplasma pneumoniae</i> pneumonia in pediatric patients. [PDF]

Transl Pediatr
Hu J, Chen H, Chen Y, Li J, Li X, Guo J, Wang Y, Shi Y.   +7 more
europepmc   +1 more source